文献速递MDS 与骨髓增殖性肿瘤白血病淋巴瘤

DDX41突变种系易感综合征患者血细胞减少及体细胞变异的患病率

Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndrome.
PubMed 文献 · Br J Haematol · 2025-03-04

该研究回顾性分析了Mayo Clinic 195例DDX41种系易感综合征患者的临床与分子特征,其中致病性种系变异占42.3%、意义未明变异占57.6%。中位年龄68.6岁,最常见诊断为骨髓增生异常综合征(40.5%)和急性髓系白血病(20.5%)。髓系肿瘤患者较无髓系肿瘤者年龄更大(中位70岁 vs 63.5岁)且男性比例更高(男女比2.3 vs 1.0)。

要点

  • DDX41种系易感综合征患者中骨髓增生异常综合征占40.5%、急性髓系白血病占20.5%。
  • 髓系肿瘤患者中78.8%核型正常,最常见体细胞变异为DDX41(34.4%)。
  • 髓系肿瘤患者较无髓系肿瘤者年龄更大(中位70岁 vs 63.5岁),男女比2.3 vs 1.0。

核心结论

  • 该研究全面描述了Mayo Clinic DDX41种系易感综合征队列的临床表型谱。

研究设计与样本

  • 回顾性分析195例在Mayo Clinic诊断和治疗的DDX41种系易感综合征患者的临床与分子特征。

主要发现

  • 种系变异中致病性变异占42.3%,意义未明变异占57.6%,共92种不同种系变异,最常见为p.Met1?(15.9%)和p.Asp140Glyfs*2(9.2%)。
  • 临床诊断包括无症状携带者10.2%、意义未明克隆性血细胞减少(CCUS)6.1%、骨髓增殖性肿瘤6.7%、骨髓增生异常综合征40.5%、急性髓系白血病20.5%、淋系肿瘤9.2%、浆细胞病6.1%和实体瘤22.5%。
  • 髓系肿瘤患者较无髓系肿瘤者年龄更大(中位70岁 vs 63.5岁),男性比例更高(男女比2.3 vs 1.0),且78.8%核型正常。
  • 最常见体细胞变异为DDX41(34.4%),其次为TET2(11.2%)、DNMT3A(9.6%)和ASXL1(9.2%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Germline variants in DDX41 (DDX41MT-germline predisposition syndrome [GPS]) are associated with predisposition to haematological malignancies (HM), including lymphoid and myeloid neoplasms (MN). We retrospectively analysed the clinical and molecular features of 195 patients diagnosed and treated at Mayo Clinic with DDX41MT-GPS. Patients with germline DDX41 pathogenic variants (42.3%) and variants of unknown significance (VUS, 57.6%) were included. The median age was 68.6 years (16.2-93.4). Ninety-two per cent were Caucasian, 64.1% were male and 30.8% had a family history of HM. There were 92 distinct germline variants among our cohort, and the most common was p.Met1? (15.9%), followed by p.Asp140Glyfs*2 (9.2%). Clinical diagnoses included asymptomatic carriers (10.2%), clonal cytopenia of undetermined significance (CCUS, 6.1%), myeloproliferative neoplasms (6.7%), myelodysplastic syndrome (40.5%), acute myeloid leukaemia (20.5%), lymphoid neoplasms (9.2%), plasma cell dyscrasias (6.1%) and solid tumours (22.5%). Patients with MN were older (median age 70 vs. 63.5 years) and more likely to be male (M:F ratio 2.3 vs. 1.0) and most patients (78.8%) with MN had a normal karyotype. The most common somatic variants involved DDX41 (34.4%), followed by TET2 (11.2%), DNMT3A (9.6%) and ASXL1 (9.2%). In summary, we have comprehensively described the spectrum of clinical phenotypes within the Mayo Clinic DDX41MT-GPS cohort.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Kusne Y, Badar T, Lasho T, et al. Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndrome. Br J Haematol. 2025. PMID: 40040251. doi:10.1111/bjh.20018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。